» Articles » PMID: 17308092

PEA-15 Inhibits Tumor Cell Invasion by Binding to Extracellular Signal-regulated Kinase 1/2

Overview
Journal Cancer Res
Specialty Oncology
Date 2007 Feb 20
PMID 17308092
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphoprotein enriched in astrocytes of 15 kDa (PEA-15) binds to extracellular signal-regulated kinase 1 and 2 (ERK1/2) mitogen-activated protein (MAP) kinases to alter ERK1/2 cellular localization and target preferences and binds to adaptors in the extrinsic cell death pathway to block apoptosis. Here, we report that PEA-15 protein expression is inversely correlated with the invasive behavior of breast cancer in an immunohistochemical analysis of a breast cancer progression tissue microarray. Short hairpin RNA-mediated inhibition of PEA-15 expression increased the invasion of PEA-15-expressing tumor cells in vitro, suggesting a causative role for PEA-15 in the inhibition of invasion. This causative role was confirmed by the finding that the enforced expression of PEA-15 in invasive tumor cells reduced invasion. The effect of PEA-15 on tumor invasion is mediated by its interaction with ERK1/2 as shown by the following: (a) PEA-15 mutants that fail to bind ERK1/2 did not inhibit invasion; (b) overexpression of ERK1 or activated MAP/ERK kinase (MEK) reversed the inhibitory effect of PEA-15; (c) when an inhibitor of ERK1/2 activation reduced invasion, PEA-15 expression did not significantly reduce invasion further. Furthermore, we find that the effect of PEA-15 on invasion seems to relate to the nuclear localization of activated ERK1/2. PEA-15 inhibits invasion by keeping ERK out of the nucleus, as a PEA-15 mutant that cannot prevent ERK nuclear localization was not able to inhibit invasion. In addition, membrane-localized ERK1, which sequesters endogenous ERK1 to prevent its nuclear localization, also inhibited invasion. These results reveal that PEA-15 regulates cancer cell invasion via its ability to bind ERK1/2 and indicate that nuclear entry of ERK1/2 is important in tumor behavior.

Citing Articles

Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.

Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q Cell Commun Signal. 2023; 21(1):190.

PMID: 37537585 PMC: 10399053. DOI: 10.1186/s12964-023-01183-4.


On the nuclear pore complex and its emerging role in cellular mechanotransduction.

Matsuda A, Mofrad M APL Bioeng. 2022; 6(1):011504.

PMID: 35308827 PMC: 8916845. DOI: 10.1063/5.0080480.


Proteomics analysis identifies PEA-15 as an endosomal phosphoprotein that regulates α5β1 integrin endocytosis.

Caliva M, Yang W, Young-Robbins S, Zhou M, Yoon H, Matter M Sci Rep. 2021; 11(1):19830.

PMID: 34615962 PMC: 8494857. DOI: 10.1038/s41598-021-99348-z.


ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.

Wang S, Wang C, Hu Y, Li X, Jin S, Liu O J Exp Clin Cancer Res. 2020; 39(1):264.

PMID: 33246486 PMC: 7693506. DOI: 10.1186/s13046-020-01770-0.


Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin.

Dilruba S, Grondana A, Schiedel A, Ueno N, Bartholomeusz C, Cinatl Jr J Cells. 2020; 9(2).

PMID: 32102425 PMC: 7072772. DOI: 10.3390/cells9020515.